Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2024-2031

Report ID: 935265 | Published Date: Dec 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 IBS-D Drugs
        1.2.3 IBS-C Drugs
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Women
        1.3.3 Men
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2016-2027)
    2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Regions
        2.2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Dynamic
        2.3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends
        2.3.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
        2.3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
        2.3.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue
        3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2016-2021)
        3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
    3.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio
        3.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2020
    3.5 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served
    3.6 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
    3.7 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Type
    4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2022-2027)

5 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application
    5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
    6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
        6.2.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
        6.2.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
        6.2.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
    6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
        6.3.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
        6.3.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
        6.3.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
    6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
        6.4.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
        6.4.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
    7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
        7.2.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
    7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
        7.3.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
    7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
        7.4.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
        8.2.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
        8.3.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region
        8.4.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
    9.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
        9.2.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
    9.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
        9.3.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
    9.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
        9.4.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
        10.2.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
        10.3.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
        10.4.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Ironwood Pharmaceuticals
        11.1.1 Ironwood Pharmaceuticals Company Details
        11.1.2 Ironwood Pharmaceuticals Business Overview
        11.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
        11.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
        11.1.5 Ironwood Pharmaceuticals Recent Development
    11.2 Bausch Health
        11.2.1 Bausch Health Company Details
        11.2.2 Bausch Health Business Overview
        11.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
        11.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
        11.2.5 Bausch Health Recent Development
    11.3 Takeda
        11.3.1 Takeda Company Details
        11.3.2 Takeda Business Overview
        11.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
        11.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
        11.3.5 Takeda Recent Development
    11.4 Sebela Pharmaceuticals
        11.4.1 Sebela Pharmaceuticals Company Details
        11.4.2 Sebela Pharmaceuticals Business Overview
        11.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
        11.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
        11.4.5 Sebela Pharmaceuticals Recent Development
    11.5 Allergan
        11.5.1 Allergan Company Details
        11.5.2 Allergan Business Overview
        11.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
        11.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
        11.5.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of IBS-D Drugs
    Table 3. Key Players of IBS-C Drugs
    Table 4. Key Players of Others
    Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2016-2021)
    Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2022-2027)
    Table 11. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends
    Table 12. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
    Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
    Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
    Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players (2016-2021)
    Table 17. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2020)
    Table 18. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
    Table 22. Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2016-2021)
    Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2016-2021)
    Table 30. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Ironwood Pharmaceuticals Company Details
    Table 63. Ironwood Pharmaceuticals Business Overview
    Table 64. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
    Table 65. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
    Table 66. Ironwood Pharmaceuticals Recent Development
    Table 67. Bausch Health Company Details
    Table 68. Bausch Health Business Overview
    Table 69. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product
    Table 70. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
    Table 71. Bausch Health Recent Development
    Table 72. Takeda Company Details
    Table 73. Takeda Business Overview
    Table 74. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product
    Table 75. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
    Table 76. Takeda Recent Development
    Table 77. Sebela Pharmaceuticals Company Details
    Table 78. Sebela Pharmaceuticals Business Overview
    Table 79. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
    Table 80. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
    Table 81. Sebela Pharmaceuticals Recent Development
    Table 82. Allergan Company Details
    Table 83. Allergan Business Overview
    Table 84. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product
    Table 85. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
    Table 86. Allergan Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2020 VS 2027
    Figure 2. IBS-D Drugs Features
    Figure 3. IBS-C Drugs Features
    Figure 4. Others Features
    Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2020 VS 2027
    Figure 6. Women Case Studies
    Figure 7. Men Case Studies
    Figure 8. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered
    Figure 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions: 2020 VS 2027
    Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2022-2027)
    Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2020
    Figure 14. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2020
    Figure 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2016-2021)
    Figure 17. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2022-2027)
    Figure 18. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
    Figure 20. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
    Figure 21. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
    Figure 22. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
    Figure 26. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
    Figure 27. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
    Figure 28. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2016-2027)
    Figure 38. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
    Figure 46. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
    Figure 47. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
    Figure 48. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
    Figure 54. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
    Figure 58. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
    Figure 59. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
    Figure 60. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
    Figure 61. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan
Frequently Asked Questions
Rx Irritable Bowel Syndrome (IBS) Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rx Irritable Bowel Syndrome (IBS) Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rx Irritable Bowel Syndrome (IBS) Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

RV Rental

RV is a motor vehicle or trailer which includes living quarters designed for accommodation. Inclu ... Read More